PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
128 hedge funds and large institutions have $335M invested in Progenics Pharmaceuticals Inc in 2019 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 44 increasing their positions, 35 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
128
Holders Change
-7
Holders Change %
-5.19%
% of All Funds
2.53%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
18
Increased
44
Reduced
35
Closed
25
Calls
$1.01M
Puts
$1.38M
Net Calls
-$367K
Net Calls Change
-$1.64M
Top Buyers
| 1 |
BC
1
Broadfin Capital
New York
|
$15.6M |
| 2 |
AA
2
AQR Arbitrage
Greenwich,
Connecticut
|
$5.37M |
| 3 |
FCM
3
Farallon Capital Management
San Francisco,
California
|
$42M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$22.4M |
| 5 |
5
BlackRock
New York
|
$72.7M |
